This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Waldorf, H. A. Articles by Murphy, G. F. Search for Related Content PubMed PubMed Citation Articles by Waldorf, H. A. Articles by Murphy, G. F.

American Journal of Pathology, Vol 138, 477-486, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Early cellular events in evolving cutaneous delayed hypersensitivity in humans

HA Waldorf, LJ Walsh, NM Schechter and GF Murphy
Duhring Dermatologic Research Laboratories, University of Pennsylvania, Philadelphia 19104.

The delayed-type hypersensitivity reaction (DHR) in human skin is prototypic for many inflammatory dermatoses. However the cellular events that precede gross lesion formation are unknown. In this study, inflammatory cell populations and adhesion molecule expression in early phases of DHR elicited by 2,4-dinitrochlorobenzene were evaluated. The first discernible event (at 1 hour) was mast cell degranulation, followed by induction of endothelial leukocyte adhesion molecule (ELAM- 1) expression on dermal postcapillary venules at 2 hours. Endothelial leukocyte adhesion molecule expression peaked at 24 hours and declined by 48 hours. In contrast, endothelial expression of intercellular adhesion molecule-1 (ICAM-1) remained at constitutive levels. Intrafollicular T-cell migration occurred independent of ICAM-1 expression and commenced as early as 4 hours after challenge. Mature, activated CD4-positive lymphocytes that expressed a helper- inducer/memory phenotype predominated in early lesions. These results demonstrate in vivo that mast cell degranulation, ELAM-1 expression, and memory T-cell-follicular interactions are key events in subclinical evolutionary stages of cutaneous DHR.

This article has been cited by other articles:

				B. B. Goldberg, D. A. Merton, J.-B. Liu, M. Thakur, G. F. Murphy, L. Needleman, A. Tornes, and F. Forsberg Sentinel Lymph Nodes in a Swine Model with Melanoma: Contrast-enhanced Lymphatic US Radiology, March 1, 2004; 230(3): 727 - 734. [Abstract] [Full Text] [PDF]

				L. J. Walsh MAST CELLSAND ORAL INFLAMMATION Crit. Rev. Oral. Biol. Med., May 1, 2003; 14(3): 188 - 198. [Abstract] [Full Text] [PDF]

				D. Baram, G. G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y. A. Mekori Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-{alpha} J. Immunol., October 1, 2001; 167(7): 4008 - 4016. [Abstract] [Full Text] [PDF]

				S E Abbot, W J D Whish, C Jennison, D R Blake, and C R Stevens Tumour necrosis factor alpha stimulated rheumatoid synovial microvascular endothelial cells exhibit increased shear rate dependent leucocyte adhesion in vitro Ann Rheum Dis, September 1, 1999; 58(9): 573 - 581. [Abstract] [Full Text]

				N. Inamura, Y. A. Mekori, S. P. Bhattacharyya, P. J. Bianchine, and D. D. Metcalfe Induction and Enhancement of Fc{epsilon}RI-Dependent Mast Cell Degranulation Following Coculture with Activated T Cells: Dependency on ICAM-1- and Leukocyte Function-Associated Antigen (LFA)-1-Mediated Heterotypic Aggregation J. Immunol., April 15, 1998; 160(8): 4026 - 4033. [Abstract] [Full Text] [PDF]